Taxpayers Federation: new report shows government pharmacare could cost far more than promised
• New report suggests annual cost of government pharmacare plan could be $10 billion more than projected
• Analysis suggests existing projections underestimate demand spike for drugs while overestimating single-buyer cost savings
By Canadian Taxpayers Federation -- Aaron Wudrick, Federal Director—— Bio and Archives--September 25, 2019
Canadian News, Opinion | Comments | Back To Full Article
OTTAWA, ON: The Canadian Taxpayers Federation today released the Universal Pharmacare Risk Analysis Report prepared by RSM Canada, which concludes that a federal government pharmacare program for prescription drugs is likely to cost far more than projected.
"Proponents of government pharmacare simply assert that it will save Canadians money, but the bottom line is that it probably won't, and is just as likely to see overall costs increase," said CTF Federal Director Aaron Wudrick. "In their rush to cheerlead for a massive new government program, it turns out pharmacare fans have been making some very optimistic assumptions."Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy